FilingSEC EDGAR6-K
NovaBridge Biosciences Appoints Charles Silberstein as New CFO
· SEC accepted
StageManagement
Filing content
NovaBridge Biosciences announced the appointment of Dr. Charles Silberstein as its new Chief Financial Officer, effective November 2, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…